Dr. Castillo participates in an international study on the visual evolution of patients with LHON

Medical content revised by - Last revision 17/11/2021
Dr. Castillo participates in an international study on the visual evolution of patients with LHON

La Dra. Lorena Castillo en su consulta. Foto: J. Casanova / ICR

The REALITY study is an observational registry of patients with LHON designed to evaluate the natural history of the three most common disease-causing mitochondrial DNA (mtDNA) mutations and the factors that influence visual outcome. The study, published in the official journal of the Royal College of Ophthalmologists, involved 11 centers in the United States and Europe, including ICR, which was the only representative from Spain. Dr. Lorena Castillo, head of the ICR Department of Neurophthalmology, was one of the LHON specialists who participated in this study on the natural history of LHON.

What is Leber’s hereditary optic neuropathy (LHON)?

Leber’s hereditary optic neuropathy (LHON), also known as Leber’s optic atrophy (LOA), was discovered in 1871 by Dr. Theodore Leber. It usually causes severe vision loss in both eyes. In most cases, it starts affecting one eye and, after a few weeks or months, affects the second eye. Its progression is rapid, with 80% of patients affected by LHON ending up legally blind one year after the onset of symptoms. Spontaneous partial visual recovery is rarely reported in the literature.

It is the most common hereditary optic neuropathy, its cause is a mitochondrial mutation and its prevalence is low, estimated at 1 per 37,000 inhabitants. It usually affects young males between 15 and 35 years of age, although it can also affect younger children and adults over 35 years of age. In women it has a much lower incidence.

Study design

To qualify for inclusion in the study, patients were required to have a diagnosis of LHON confirmed by genotyping for one of the three primary mutations (m.11778G> A in ND4, m.3460G> A in ND1 and m.14484T> C in ND6). Forty-four patients with LHON were included in the study; 27 (61%) carried the ND4 mutation, 8 (18%) carried the ND1 mutation and 9 (21%) carried the ND6 mutation. The included patients were between 4 and 71 years old at the onset of vision loss.

In addition, patients were included only if they had undergone at least two visual function assessments, performed at any time between the first and third year after the onset of vision loss. There was no age restriction and patients could have received idebenone or any other treatment. The primary source of demographic and clinical data was the medical records of enrolled patients.

Study contributions

The two most important predictors of visual outcome in LHON are the underlying causative mtDNA mutation and the age of onset of vision loss. In the REALITY study, NOHL patients carrying the ND6 mutation achieved better final vision compared to those carrying the ND4 and ND1 mutations. Likewise, the literature reports that children who are affected at age 12 years or younger achieve significantly better vision compared to patients with adult-onset LHON, which the REALITY study was also able to confirm.

Dr. Lorena Castillo explains, “The REALITY registry has a number of limitations due to the retrospective nature of its study design and the relatively small sample size of 44 patients. Nevertheless, the findings of this study confirm the better visual outcome with childhood-onset LHON and the poor visual prognosis for patients with the ND4 mutation who were at least 15 years old at disease onset.”

The results of the REALITY study, in which Dr. Castillo participated, are available here.

Related articles

Leber Hereditary Optic Neuropathy

What is Leber Hereditary Optic Neuropathy? Leber Hereditary Optic Neuropathy (LHON), also known as Leber Optic Atrophy, was named after Doctor Theodore Leber, who described in 1871 a characteristic pattern of sudden vision loss in young men with family history of blindness. It is the most common hereditary optic neuropathy, it is caused by a […]

Dando a conocer la NOHL, que afecta a jóvenes adultos y produce ceguera

La Dra. Castillo, líder europea en LHON (siglas en inglés de Neuropatía Óptica Hereditaria de Leber), ha sido entrevistada por la plataforma digital Pharmaphorum, donde ha explicado qué es esta enfermedad y por qué es importante conocerla.

La Dra. Castillo habla sobre Terapia Génica en NOHL en el XI Curso de Actualización en Neuroftalmología

La Dra. Lorena Castillo, responsable del Departamento de Neuroftalmología y del Departamento de Docencia del Institut Català de Retina, participó como ponente en el XI Curso de Actualización en Neuroftalmología que se celebró los pasados 15 y 16 de febrero en Madrid. Este curso es un evento bienal que lleva realizándose 20 años y que […]

La NOHL, única enfermedad mitocondrial que puede estudiarse “únicamente asomándose al ojo”

Más de 150 asistentes participaron en el encuentro científico dedicado a la Neuropatía Óptica Hereditaria de Leber, celebrado entre el 12 y el 14 de mayo pasados. La NOHL (o LHON, por sus siglas en inglés) es una enfermedad poco habitual que reduce la agudeza visual y que se debe a una alteración genética mitocondrial. […]

Do you have any questions?

Contact us or request an appointment with one of our Neuro-Ophthalmology specialists.

Visit us at:

ICR Pau Alcover

C. Pau Alcover 67
08017 Barcelona See map

ICR Ganduxer Headquarters

c/Ganduxer,117
08022 Barcelona See map

ICR Terrassa

77, Del Nord St.
08221 Terrassa See map

ICR Service at Clínica Ntra. Sra. del Remei

c/ de l'Escorial,148
08024 Barcelona See map

Clínica Bonanova Surgical Center

Passeig Bonanova, 22
08022 Barcelona See map

Clinica Bonanova Tests and Treatments

c/ Mandri, 63
08022 Barcelona See map

ICR Pau Alcover

Telephone number (+34) 93 378 23 19

Opening hours:
Monday to Friday from 8 am to 9 pm. Saturday from 8 am to 2 pm.

How to get there More information

ICR Ganduxer Headquarters

Telephone number 93 254 79 20
Emergencies phone number: 93 418 72 27

Opening hours:
Monday to Friday 8 a.m. to 9 p.m.
Saturdays 9 a.m. to 2 p.m.

How to get there More information

ICR Terrassa

Telephone number +34 93 736 34 40

Opening hours:
Monday to Friday from 8:30 a.m. to 2 p.m. and 3 p.m. to 8 p.m.

How to get there More information

ICR Service at Clínica Ntra. Sra. del Remei

Telephone number 902 10 10 50

Opening hours:
Every day from 3 p.m. to 8 p.m. and Friday mornings from 10 a.m. to 2 p.m.

How to get there More information

Clínica Bonanova Surgical Center

Telephone number 934 34 09 25

Opening hours:
Monday to Friday from 7:30 a.m. to 8:30 p.m.

How to get there More information

Clinica Bonanova Tests and Treatments

How to get there More information